Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluations of Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Ataxia Teleangiectasia Patients

NCT01255358 is registered in ClinicalTrials.gov with Quince Therapeutics S.p.A. as lead sponsor.

NCT NCT01255358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01255358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluations of Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Ataxia Teleangiectasia Patients
Lead sponsor
Quince Therapeutics S.p.A.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
December 31, 2011
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

genetic syndrome, nervous system disorder